
Dr Kevin Martell
@kevinmartell
Radiation Oncologist.
Views expressed are my own and do not reflect those of my employer.
ID: 61348939
30-07-2009 01:13:13
100 Tweet
189 Followers
157 Following


.AHS_CancerCare #TomBakerCancerCentre Radiation Oncologists at our start line of the #CARO2020 #CAROVSM2020 CARO-ACRO Dr. Pamela Catton Memorial Run / Walk for Canadian Radiation Oncology Foundation (CROF) Let’s go!


Is hypofractionated WPRT safe in high-ish risk prostate cancer patients treated with HDR-BT boost? Check out the HOPE-Trial below! To our knowledge, this is the first RCT investigating this question. rdcu.be/b8jLy Dr Kevin Martell Glenn Bauman, MD George Rodrigues @axarifin


.Hein Van Poppel: "PSA testing was discouraged, because #ProstateCancer diagnosis automatically led to active treatment. We were not able to discriminate between significant and insignificant cancer." "But times have changed!" 👇 #EPAD20





Hey twitterverse/GU gurus. Wondering what your thoughts are. Patients with 1)conventionally detected vs 2)PSMA detected met post RP. You're SBRT/SABRing the met ... Do you treat the prostate bed Dr. Andrew Loblaw Daniel E Spratt @SouMyajiT_RO Lucas C Mendez Gerard Morton Danny Vesprini

Interesting! My fear is it might be more nuanced if there were several risk factors for local recurrence but no gross disease. As Danny Vesprini hinted it's tempting to check if we've cured a patient after SBRT. TBCC considers ARAT and SBRT for these patients. Prostate bed is grey zone




New FIGO staging taking histology and substantial LVSI into account DrKamrava Ann Klopp Hima Bindu Musunuru Andrew Keller #gynsm




A rockstar radonc Dr. Andrew Loblaw once told me it’s always comforting when you find a study that confirms your biases. This gem I’ve been waiting for for a while now… thelancet.com/journals/lanon…
